Next-gen sequencing, mass spec to be used in PTSD consortium work

08/13/2013 | GenomeWeb Daily News (free registration)

The STRONG STAR Consortium to Alleviate PTSD, also known as the STRONG STAR-CAP, will use next-generation sequencing to look at structural contributors in diagnosing and treating PTSD, as well as mass spectrometry to discover protein biomarkers that could help predict PTSD risk. The consortium, led by the University of Texas Health Science Center in San Antonio, is receiving a $45 million grant from the Defense Department and Department of Veterans Affairs to support the research.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations